Browne Jacobson
 
 
Remember me:
Skip Navigation Links
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

30/07/2015
Limited-life venture capital trust Puma Investments has invested £11 million in care home operator Abbey Healthcare, HealthInvestor can reveal.
29/07/2015
The number of NHS acute trusts who failed to hit nurse staffing levels in April this year has risen to 84% compared to 76% in the same month in 2014.
29/07/2015
AIM-listed CareTech has agreed to acquire the entire issued share capital of Spark of Genius for £9.23 million.
28/07/2015
Spire Healthcare has announced that discussions with a third party to acquire Spire St Saviour’s hospital have fallen through.
27/07/2015
Burton Hospitals NHS Foundation Trust and Health Innovation Partners have teamed up through a ten-year joint venture to improve efficiency at the trust.




Four Seasons Health Care’s financial performance over the past 12 months has made for bleak reading, but new division head Tim Hammond tells Ploy Radford he is warming to the task
Read more...
The Turkish healthcare market is buzzing with opportunities to delight European investors, finds Adrian Murdoch
Read more...
HealthInvestor podcasts

Simplyhealth’s exit from the PMI space marked a notable change of direction for the firm. Sunniva Davies-Rommetveit asks group CEO Romana Abdin what lay behind it
Read more...

Browne Jacobson
Saif Razvi, a consultant neurologist at NHS Scotland Health Boards, tells HealthInvestor about the NHS’ recent partnership with Quarriers, with which it jointly operates the William Quarrier Scottish Epilepsy Centre
How should private providers engage with an NHS under a Conservative majority, asks Richard Sloggett, associate director at Hanover Communications
Clare Connell and Hannah Hurley of Connell Consulting investigate the opportunities for investors north of the border
Jeremy Hunt has declared war on staffing agency prices. Ploy Radford asks whether temp agencies and their backers are in for a battle or not
The UK healthcare services market has seen a wave of new investors coming in. Will the trend continue at the expense of private equity or will it fight back, asks Kirsten Noben

Click here to search all feature articles